Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bogus diabetes test strips

This article was originally published in The Gray Sheet

Executive Summary

Counterfeit test strips distributed in the U.S. by Medical Plastic Devices of Quebec, Canada, and Champion Sales of Brooklyn, N.Y., for use with various models of Johnson & Johnson/LifeScan One Touch blood glucose monitors could give incorrect readings, leading to the administration of too much or too little insulin and potential complications, according to an Oct. 13 FDA release. Patients in possession of One Touch Basic/Profile (lot #272894A, 2619932 or 2606340) or One Touch Ultra (lot #2691191) strips should discontinue use and contact their physician, FDA says. The agency is investigating the matter. Abbott and Roche also have been targeted by counterfeiters in recent years (1"The Gray Sheet" March 8, 2004, p. 15)...

You may also be interested in...



Abbott Blood Glucose Test Strips Target Of Alternate Source Market

FDA is investigating sales of counterfeit packages of Precision QID blood glucose test strips manufactured by Abbott Labs

Basilea Stresses Derazantinib's FGFR Kinase Differentiation

Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.

 

ATMPs Put EU Cross-Border Healthcare On The Map

Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.

UsernamePublicRestriction

Register

MT024076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel